Skip to main content
. 2023 Apr 14;3(4):576–591. doi: 10.1158/2767-9764.CRC-22-0477

FIGURE 4.

FIGURE 4

IOA-244 remodels the immune microenvironment and allow ICB-driven antitumor immune response. Flow cytometry analysis from CT26 tumors showing quantification of CD45+ cells (A), CD8/CD45 (B), CD4/CD45 (C), mMDSC/CD45 (D), gMDSC/CD45 (E). F and G, Efficacy of IOA-244 alone or combined with anti-PD-L1 in the LLC (H and I), A20 (H–I) and Pan-02 (J and K) syngeneic mouse tumor models, measuring tumor volumes. Statistics shown are two-way ANOVAs (Tukey multiple comparison test).